News
Analysis Group Congratulates Authors of Four Articles Distinguished with Nominations for 2026 Concurrences Antitrust Writing Awards
Analysis Group congratulates 12 of its competition experts, the authors of four articles nominated for the 2026 Concurrences Antitrust Writing Awards. A joint initiative with The George Washington University Competition Law Center, the Antitrust Writing Awards will present both juried and readers’ choice winners at a gala dinner in Washington, DC, on March 24, 2026, the day before the opening of the American Bar Association’s Antitrust Spring Meeting.
Online voting for readers’ choice awards is open until March 3, 2026.
Our nominated articles:
Academic Articles: Mergers
- “Sustainability Considerations in EU Merger Control,” Jay Modrall, Associate Claire Paoli, and Vice President Joshua White; Journal of Antitrust Enforcement, November 25, 2025
Business Articles: General Economics
- “The Relationship Between Pricing Transparency and Price Competition in the US Health Care Industry,” Manager Juan Carvajal, Vice President Christopher Ody, and Affiliate Christopher Whaley; American Bar Association Antitrust Law Section Website, November 5, 2024
- “The Role of Private Equity in the Entrepreneurial Ecosystem,” Managing Principal Lauren Hunt, Vice President Dasha Anosova, and Affiliate Yael Hochberg; American Bar Association Antitrust Law Section Website, June 16, 2025
Business Articles: Concerted Practices
- “Recent Developments in Labor Market Antitrust Enforcement in the United States, Europe, Canada, and China,” Managing Principal Jee-Yeon Lehmann, Manager Olivia Althans, and Vice Presidents Yeseul Hyun and Federico Mantovanelli; American Bar Association Antitrust Law Section Website, October 11, 2024
View the list of nominated Analysis Group Articles
Associated People
Joshua White
Managing PrincipalMr White is a consulting and testifying economist who specialises in applying microeconomics and sophisticated econometric modelling to complex litigation and merger-related questions, primarily in matters involving the health care, financial services and technology industries. He has supported clients in various jurisdictions and industries in follow-on competition damages litigation, assessing overcharge, upstream and downstream pass-on and volume effects. He has served as a testifying expert in the UK Upper Tribunal (Lands Chamber), the UK Competition Appeal Tribunal and the Amsterdam District Court on competition cases.
Mr White has supported high-profile companies with complex merger reviews across multiple jurisdictions, including in the Veolia/Suez, LVMH/Tiffany, Sika/MBCC and Eutelsat/OneWeb mergers. He has also provided evidence to the UK’s Competition and Markets Authority (CMA) and the European Commission (EC), including on behalf of clients involved in cartel investigations, abuse of dominance investigations and mergers. Mr White has also provided support to European financial and competition regulators in coordinated conduct investigations.
Mr White has extensive experience addressing competition and intellectual property (IP) issues in matters related to cutting-edge pharmaceutical products and FRAND licensing questions. As part of this work, he has supported a number of scientific and technical experts in front of courts and regulatory bodies. He also regularly supports pharmaceutical clients on competition issues around market access, pricing, denigration and competition from generic manufacturers.
Mr White has worked in a number of jurisdictions, including the UK, the European Union, Switzerland, Australia, New Zealand, South Africa, Canada, Japan, Korea, the Netherlands, Belgium and the US. His writing has been published in an array of journals, including the Journal of European Competition Law & Practice, the Competition Law Journal and the Journal of Antitrust Enforcement, and he regularly speaks at international competition law and policy conferences.